Nucleic Acid Chemical Biology: An Honorary Issue for Professor Li-He Zhang on the Occasion of His 85th Birthday
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Chemical Biology".
Deadline for manuscript submissions: closed (30 September 2022) | Viewed by 27643
Special Issue Editors
Interests: nulceic acid drugs; gene silencing; gene editing; gene photoregulation; oligonucleotide modification
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In recent years, an increasing number of nucleic acid drugs have been used in clinical applications. Nucleic acids have been hot research targets for both chemists and biologists. Many types of functional oligonucleotides have been developed, including CRISPR gRNA, lncRNA, miRNA, aptamers, siRNA, antisense ODN, etc., and their precise modifications have also been achieved for both scientific research and pharmaceutical applications in vivo and in clinic. At the same time, we still face unsolved key problems for nucleic acid drugs, such as off-target effects, enzymatic stability and immunoreaction, etc.
Professor Li-He Zhang (born in 1937) is a key player in nucleic acid chemistry and chemical biology in China. He is a Professor at State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, and an Academician of the Chinese Academy of Sciences (1995). He graduated from the Department of Pharmacy in 1958 and obtained his graduate diploma on medicinal chemistry in 1967 from Beijing Medical College. He worked as a research associate from 1981 to 1983 in the Department of Chemistry, University of Virginia, USA. In 1985, he became professor of medicinal chemistry at the School of Pharmaceutical Sciences, Beijing Medical University, and was appointed as Dean of the School of Pharmaceutical Sciences, Beijing Medical University (1987–1999) and Director of the Chemistry Division of the National Natural Science Foundation of China (1999-2006). He is the Associate Editor of Eur. J. Med. Chem. and J. Chem. Chin. Univ.; Editor in Chief of J. Chin. Med. Chem., and he is also on the Editorial Boards of a number of scientific journals, including Med. Res. Rev., Curr. Top. Med. Chem., and Org. Biomol. Chem., ChemMedChem. His main research areas include chemistry and chemical biology of nucleosides, nucleotides, and oligonucleotides. He has conducted systematic studies on the chemical and biological activity of intracellular messenger cADPR and cAMP. He has also made outstanding contributions to the research areas of ribozyme cleavage mechanism, the nature and recognition of artificial oligonucleotides, and anticancer and antiviral drugs of nucleosides and nucleotides.
The journal is pleased to be publishing an honorary Special Issue in honor of Professor Li-He Zhang for his outstanding contributions on nucleosides, nucleotides, and oligonucleotides on the occasion of his 85th birthday in 2022. This Special Issue of Molecules welcomes the submission of unpublished manuscripts of original work or reviews on “Nucleosides, Nucleotides, and Oligonucleotides”.
Prof. Dr. Xinjing Tang
Dr. Changmai Chen
Guest Editors
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.